TRED Annual Report FY2016

27 NSU OFFICE OF CLINICAL RESEARCH Leading Therapeutic Areas in Clinical Research DENTIFRICES AND IMPLANTS College of Dental Medicine PEDIATRIC CONSTIPATION, CHRONIC FATIGUE SYNDROME College of Osteopathic Medicine PREVALENCE OF VITREOMACULAR DISEASE College of Optometry NUTRACEUTICAL INTERVENTION FOR OXIDATIVE STRESS College of Pharmacy NUTRACEUTICAL INTERVENTION Mailman Segal Center for Human Development NUTRACEUTICAL SUPPLEMENTATION IMPACT ON BODY COMPOSITION College of Health Care Sciences ORTHOPEDIC DEVICES FOR METASTATIC BONE CANCER H. Thomas Temple, M.D. Service Transactions FY 2016 Financial (14%) Clinical Coordinating (37%) Training (12%) Contracts (4%) Business Development (5%) Community Service (11%) PI Consults (17%) College of Dental Medicine $938,800 (72%) College of Osteopathic Medicine $177,625 (13%) College of Pharmacy $52,875 (4%) College of Health Sciences $12,500 (1%) H. Thomas Temple, M.D. $55,000 (4%) College of Optometry $74,360 (6%) College of Dental Medicine $2,413,110.00 (53%) College of Osteopathic Medicine $1,474,826.50 (33%) College of Pharmacy $102,875.00 (2%) College of Optometry $471,074.33 (11%) College of Health Sciences $12,500 (>1%) H. Thomas Temple, M.D. $55,000 (1%) FY 2016 Total Encounters by Percentage Clinical Trial Funding FY 2016 Total Clinical Trial Funding FY 2009–FY 2016 Funding amount for 2016 clinical trials per college and percentage of FY 2016 $1,311,160 total Funding amount from FY 2009 to FY 2016 $4,529,385.83 total

RkJQdWJsaXNoZXIy NDE4MDg=